EndoQuest Robotics is a leading innovator in the development of transformative endoluminal robotic technologies. EndoQuest is focused on addressing unmet needs in gastrointestinal (GI) medicine and endoluminal surgery by enabling physicians with unprecedented surgical access, precision, and flexibility. The company's proprietary technology is designed to navigate and perform scar-free procedures through the body's natural orifices, allowing for the least invasive surgical approach. Since EndoQuest Robotics was founded, the company has collaborated extensively with healthcare providers, researchers, and industry partners to advance the development of its revolutionary flexible robotic system with the goal of improving patient outcomes and redefining a new standard in minimally invasive surgery. For additional information, visit the company’s website at www.endoquestrobotics.com. EndoQuest’s Endoluminal Surgical System is under development, has not been cleared by the FDA, and is not yet available for commercial sale in the United States.
$42M sweet spot round size
2017
$42M
from 3 investors over 1 rounds
EndoQuest Robotics raised $42M on January 4, 2024
Investors: CE-Ventures, McNair Interests and + 1 Other investor